Search for: "Holding v. State" Results 1401 - 1420 of 69,976
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Jun 2015, 8:13 am by Venkat Balasubramani
This ruling comes on the heels of the District of Columbia Circuit’s holding that state anti-SLAPP laws can’t be invoked in federal court. [read post]
13 Dec 2023, 5:08 am by Andrew Lavoott Bluestone
(Atsco Footwear Holdings, LLC v KBG, LLC, 193 AD3d 493, 494-495 [1st Dept 2021]; An-Jung v Rower, LLC 173 AD3d 488,488 [1st Dept 2019] [holding breach of contract claims should be dismissed in light of defendants’ account stated defense where retainer required objections to be raised within 30 days of receipt of the invoice, plaintiff timely paid the invoices, and did not object to any of them until two months after she received the last one].) [read post]
25 Jul 2012, 7:03 am by Rosalind English
RT (Zimbabwe) and others (Respondents) v Secretary of State for the Home Department [2012] UKSC 38 - read judgment It is no answer to a refugee claim to say that the individual concerned should avoid persecution by lying and feigning loyalty to a regime which he does not support. [read post]
24 Jun 2016, 11:53 am by MBettman
On June 10, 2015, the Supreme Court of Ohio heard oral argument in the case of State of Ohio v. [read post]
2 Jun 2008, 4:25 am
Cuellar was driving a Volkswagen Beetle south on State Highway 77 in Texas, approximately 100 miles from the Mexican border. [read post]
17 Mar 2007, 1:10 am
Therefore, the trial court erred in allowing the State to ask petitioner "were-they-lying" questions. [read post]
7 Feb 2017, 4:58 pm by John Stigi
  The United States District Court for the Northern District of California granted that motion, holding that plaintiffs had not alleged falsity or materiality. [read post]
12 Jan 2007, 6:20 pm
Biogen IDEC, decided just a month after Merck in the District of Maryland, the district court interpreted Merck's holding in the broadest possible manner, dismissing Classen's claims against Biogen IDEC ("Biogen") and GlaxoSmithKline ("GSK") when the defendants successfully argued that their allegedly infringing acts of research tool use fell within the safe harbor provision of 271(e)(1) as construed in Lilly and Merck. n89footnote 89 states: Classen… [read post]